17,99 €
inkl. MwSt.

Versandfertig in 1-2 Wochen
payback
9 °P sammeln
  • Broschiertes Buch

The aim of this book is to provide guidance for individuals who wish to learn about the exciting field of clinical research. The reader will gain a deep understanding of the approval process for modern pharmaceuticals used to treat cancer and other types of diseases. The reader will also learn the background of the various pharmaceutical companies and agencies such as the United States Food and Drug Administration working on these clinical research trials. The reader will gain a general knowledge of clinical research trials and how they are conducted. The primary focus will be the clinical…mehr

Produktbeschreibung
The aim of this book is to provide guidance for individuals who wish to learn about the exciting field of clinical research. The reader will gain a deep understanding of the approval process for modern pharmaceuticals used to treat cancer and other types of diseases. The reader will also learn the background of the various pharmaceutical companies and agencies such as the United States Food and Drug Administration working on these clinical research trials. The reader will gain a general knowledge of clinical research trials and how they are conducted. The primary focus will be the clinical trials process in the United States of America. An explanation of international clinical trials conduct is also mentioned in this book.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
John Battish is a dedicated Clinical Research Site Manager who has monitored various clinical trials for pharmaceutical companies such as Pfizer, Merck, Sanofi-Aventis, Kite, LabCorp, and Morphotek. He explains his vast medical career which began at the University of Pennsylvania in the gene therapy department in 1999. John Battish in 2008 earned his Masters of Science in Clinical Research Organization and Management from Drexel University Medical School in Philadelphia, Pennsylvania. He then went on to help manage and monitor clinical trials which contributed to the United States Food and Drug Administration approval for key pharmaceutical drugs now used as standard treatment for various cancer therapies. A few of these key drugs using CAR T-Cell Therapy are based on the gene therapy programs that John Battish originally worked on.